Naslov
Kisspeptin as a promising oocyte maturation trigger for in vitro fertilisation in humans

Autori
Kasum, Miro ; Franulić, Daniela ; Čehić, Ermin ; Orešković, Slavko ; Lila, Albert ; Ejubović, Emina

Izvornik
Gynecological Endocrinology (0951-3590) 33 (2017), 8; 583-587

Vrsta, podvrsta i kategorija rada
Radovi u časopisima, pregledni rad, znanstveni

Ključne riječi
vajnski administrator ; IVF ; kisspeptin ; okidac sazrijevanja jajnih stanica ; fizioloski mehanismi
(Exogenous administration ; IVF ; kisspeptin ; oocyte maturation trigger ; physiological mechanisms)

Sažetak
The aim of this review is to analyse the effectiveness of exogenous kisspeptin administration as a novel alternative of triggering oocyte maturation, instead of currently used triggers such as human chorionic gonadotropin (hCG) or gonadotropin releasing hormone (GnRH) agonist, in women undergoing in vitro fertilisation (IVF) treatment. Kisspeptin has been considered a master regulator of two modes of GnRH and hence gonadotropin secretion, pulses and surges. Administration of kisspeptin-10 and kisspeptin-54 induces the luteinising hormone (LH) surge required for egg maturation and ovulation in animal investigations and LH release during the preovulatory phase of the menstrual cycle and hypothalamic amenorrhoea in humans. Exogenous kisspeptin-54 has been successfully administered as a promising method of triggering oocyte maturation, following ovarian stimulation with gonadotropins and GnRH antagonists in women undergoing IVF, due to its efficacy considering achieved pregnancy rates compared to hCG and GnRH agonists. Also, its safety in patients at high risk of developing ovarian hyperstimulation syndrome is noteworthy. Nevertheless, further studies would be desirable to establish the optimal trigger of egg maturation and to improve the reproductive outcome for women undergoing IVF treatment.

Izvorni jezik
Engleski

POVEZANOST RADA